source
- Actinogen’s Alzheimer’s drug Xanamem fails pivotal trial, shares plunge over 80%Actinogen Medical, an Australian biotech, reported that its only candidate, Xanamem (emestedastat), did not meet the primary endpoint in a Phase 2b/3 study in patients with mild to moderate Alzheim…
- Early Alert: B. Braun Medical Inc. Updates Use Instructions for Caresite Micro Luer Access DeviceBBMI corrects Caresite devices due to issue with internal piston remaining depressed following disconnection, preventing the valve from fully closing.